JAK3/BTK-IN-2

TargetMol
Product Code: TAR-T9813
Supplier: TargetMol
CodeSizePrice
TAR-T9813-5mg5mg£430.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9813-10mg10mg£613.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9813-25mg25mg£997.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9813-50mg50mg£1,458.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9813-100mg100mg£2,155.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C

Images

1 / 1

Further Information

Bioactivity:
JAK3/ BTk-in-2 is a potent JAK3/BTK inhibitor. JAK3/ BTk-in-2 inhibits both BTK and JAK3, which are two important targets IN autoimmune diseases. JAK3/ BTk-in-2 simultaneously inhibits the BTK/JAK3 signaling pathway, showing a synergistic effect. JAK3/ BTk-in-2 has the potential to treat diseases associated with abnormal JAK3 and BTK activity.
CAS:
2674036-93-0
Molecular Weight:
476.57
Pathway:
Tyrosine Kinase/Adaptors|Angiogenesis|JAK/STAT signaling|Stem Cells|Chromatin/Epigenetic
Purity:
0.98
SMILES:
N(C1=C2C(=CNC2=NC(NC3=CN(N=C3)C4CCOCC4)=N1)C5CC5)[C@H]6CN(C(C=C)=O)CCC6
Target:
BTK|JAK

References

Guobao Zhang, et al. Pyrimidopyrroles. Patent WO2021147952A1.